APO RESEARCH · REPORT
Azelastine
Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.
Product & engineering
Understand the product.
Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.
Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth
Selected research
Industry Research
Azelastine Industry Research Report 2026
Market perspective
Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.
Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth
Global Azelastine includes Viatris, Apotex, Yunfeng Pharma, Sun Pharma, Amneal Pharmaceuticals, Zhongsheng Pharma, Hikma Pharmaceuticals, Perrigo, Alkem Labs and Jiangxi Zhenshiming Pharmaceutical, etc. Global top 3 companies hold a share over 57%. Asia-Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share approximately 20% each.
Read the full market overview
Report Scope
This report quantifies the global Azelastine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Azelastine Market by Company
Viatris
Apotex
Yunfeng Pharma
Sun Pharma
Amneal Pharmaceuticals
Zhongsheng Pharma
Hikma Pharmaceuticals
Perrigo
Alkem Labs
Jiangxi Zhenshiming Pharmaceutical
Azelastine Segment by Type
Nasal Spray
Eye Drops
Others
Azelastine Segment by Distribution Channel
Hospital
Retail Pharmacy
Others
Azelastine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azelastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azelastine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azelastine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Azelastine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Azelastine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Azelastine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nasal Spray
- Eye Drops
- Others
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- Viatris
- Apotex
- Yunfeng Pharma
- Sun Pharma
- Amneal Pharmaceuticals
- Zhongsheng Pharma
- Hikma Pharmaceuticals
- Perrigo
- Alkem Labs
- Jiangxi Zhenshiming Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Azelastine Market Size (2021-2032)
- 2.2.2 Global Azelastine Sales (2021-2032)
- 2.2.3 Global Azelastine Market Average Price (2021-2032)
- 2.3 Azelastine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nasal Spray
- 2.3.3 Eye Drops
- 2.3.4 Others
- 2.4 Azelastine by Distribution Channel
- 2.4.1 Market Value Comparison by Distribution Channel (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Retail Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Azelastine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Azelastine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Azelastine Revenue of Manufacturers (2021-2026)
- 3.4 Global Azelastine Average Price by Manufacturers (2021-2026)
- 3.5 Global Azelastine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Azelastine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Azelastine, Product Type & Application
- 3.8 Global Manufacturers of Azelastine, Established Date
- 3.9 Global Azelastine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Viatris
- 4.1.1 Viatris Company Information
- 4.1.2 Viatris Business Overview
- 4.1.3 Viatris Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Viatris Azelastine Product Portfolio
- 4.1.5 Viatris Recent Developments
- 4.2 Apotex
- 4.2.1 Apotex Company Information
- 4.2.2 Apotex Business Overview
- 4.2.3 Apotex Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Azelastine Product Portfolio
- 4.2.5 Apotex Recent Developments
- 4.3 Yunfeng Pharma
- 4.3.1 Yunfeng Pharma Company Information
- 4.3.2 Yunfeng Pharma Business Overview
- 4.3.3 Yunfeng Pharma Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yunfeng Pharma Azelastine Product Portfolio
- 4.3.5 Yunfeng Pharma Recent Developments
- 4.4 Sun Pharma
- 4.4.1 Sun Pharma Company Information
- 4.4.2 Sun Pharma Business Overview
- 4.4.3 Sun Pharma Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sun Pharma Azelastine Product Portfolio
- 4.4.5 Sun Pharma Recent Developments
- 4.5 Amneal Pharmaceuticals
- 4.5.1 Amneal Pharmaceuticals Company Information
- 4.5.2 Amneal Pharmaceuticals Business Overview
- 4.5.3 Amneal Pharmaceuticals Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Amneal Pharmaceuticals Azelastine Product Portfolio
- 4.5.5 Amneal Pharmaceuticals Recent Developments
- 4.6 Zhongsheng Pharma
- 4.6.1 Zhongsheng Pharma Company Information
- 4.6.2 Zhongsheng Pharma Business Overview
- 4.6.3 Zhongsheng Pharma Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zhongsheng Pharma Azelastine Product Portfolio
- 4.6.5 Zhongsheng Pharma Recent Developments
- 4.7 Hikma Pharmaceuticals
- 4.7.1 Hikma Pharmaceuticals Company Information
- 4.7.2 Hikma Pharmaceuticals Business Overview
- 4.7.3 Hikma Pharmaceuticals Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hikma Pharmaceuticals Azelastine Product Portfolio
- 4.7.5 Hikma Pharmaceuticals Recent Developments
- 4.8 Perrigo
- 4.8.1 Perrigo Company Information
- 4.8.2 Perrigo Business Overview
- 4.8.3 Perrigo Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Perrigo Azelastine Product Portfolio
- 4.8.5 Perrigo Recent Developments
- 4.9 Alkem Labs
- 4.9.1 Alkem Labs Company Information
- 4.9.2 Alkem Labs Business Overview
- 4.9.3 Alkem Labs Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alkem Labs Azelastine Product Portfolio
- 4.9.5 Alkem Labs Recent Developments
- 4.10 Jiangxi Zhenshiming Pharmaceutical
- 4.10.1 Jiangxi Zhenshiming Pharmaceutical Company Information
- 4.10.2 Jiangxi Zhenshiming Pharmaceutical Business Overview
- 4.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolio
- 4.10.5 Jiangxi Zhenshiming Pharmaceutical Recent Developments
5 Global Azelastine Market Scenario by Region
- 5.1 Global Azelastine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Azelastine Sales by Region: 2021-2032
- 5.2.1 Global Azelastine Sales by Region: 2021-2026
- 5.2.2 Global Azelastine Sales by Region: 2027-2032
- 5.3 Global Azelastine Revenue by Region: 2021-2032
- 5.3.1 Global Azelastine Revenue by Region: 2021-2026
- 5.3.2 Global Azelastine Revenue by Region: 2027-2032
- 5.4 North America Azelastine Market Facts & Figures by Country
- 5.4.1 North America Azelastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Azelastine Sales by Country (2021-2032)
- 5.4.3 North America Azelastine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Azelastine Market Facts & Figures by Country
- 5.5.1 Europe Azelastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Azelastine Sales by Country (2021-2032)
- 5.5.3 Europe Azelastine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Azelastine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Azelastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Azelastine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Azelastine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Azelastine Market Facts & Figures by Country
- 5.7.1 South America Azelastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Azelastine Sales by Country (2021-2032)
- 5.7.3 South America Azelastine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Azelastine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Azelastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Azelastine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Azelastine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Azelastine Sales by Type (2021-2032)
- 6.1.1 Global Azelastine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Azelastine Sales Market Share by Type (2021-2032)
- 6.2 Global Azelastine Revenue by Type (2021-2032)
- 6.2.1 Global Azelastine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Azelastine Revenue Market Share by Type (2021-2032)
- 6.3 Global Azelastine Price by Type (2021-2032)
7 Segment by Distribution Channel
- 7.1 Global Azelastine Sales by Distribution Channel (2021-2032)
- 7.1.1 Global Azelastine Sales by Distribution Channel (2021-2032) & (K Units)
- 7.1.2 Global Azelastine Sales Market Share by Distribution Channel (2021-2032)
- 7.2 Global Azelastine Revenue by Distribution Channel (2021-2032)
- 7.2.1 Global Azelastine Sales by Distribution Channel (2021-2032) & (US$ Million)
- 7.2.2 Global Azelastine Revenue Market Share by Distribution Channel (2021-2032)
- 7.3 Global Azelastine Price by Distribution Channel (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Azelastine Value Chain Analysis
- 8.1.1 Azelastine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Azelastine Production Mode & Process
- 8.2 Azelastine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Azelastine Distributors
- 8.2.3 Azelastine Customers
9 Global Azelastine Analyzing Market Dynamics
- 9.1 Azelastine Industry Trends
- 9.2 Azelastine Industry Drivers
- 9.3 Azelastine Industry Opportunities and Challenges
- 9.4 Azelastine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst